- PDF Version (105K) - Print Friendly - Help

Health, Nutrition and Related Claims: Enabling Provisions in New Zealand Law

10 Additional information for submitters

Comments from all those with an interest in any aspect of the proposals presented in this document are invited. Clear and concise comments will assist in ensuring that the significance of your comments is understood.

The following points may be of assistance in preparing comments:

• some questions are included below to assist you in providing comment on this paper

• wherever possible, comments should be specific to a particular section of the document

• comments should be to the point and, where possible, give reasons and data in support

• the use of examples to illustrate particular points is encouraged

• a number of copies may be made of your comments so please ensure that your comments are clear, preferably made in black ink or typewritten.

10.1 Requirements for submissions

Submitters are asked to include the following information in submissions:

• the title of this discussion document

• name and title of submitter

• organisation's name (if applicable)

• extent of internal consultation within organisation undertaken in preparing submission

• submitter's address and contact details (phone, fax, e-mail if available)

• the number(s) of the section(s) commented on, beside each comment.

10.2 Address

Please send your submission to:

Howard Staveley

Policy Analyst

New Zealand Food Safety Authority

PO Box 2835

Wellington – New Zealand

Phone: (04) 894 2690

Facsimile: (04) 894 2583

Email: howard.staveley@nzfsa.govt.nz

10.3 Closing date for submissions

The closing date for submissions is 14 May 2007.

10.4 Submission format

This format is included to assist interested parties in formulating submissions:

Your view

Name:

Address:

1. The consultation process

2. The need for regulatory change

3. Options:

a. Amend the Medicines Act 1981

b. Repeal and replace the Medicines (Related Products (Exempted Food)) Regulations 2003

c. Rely on the new Therapeutic Products Bill currently before Parliament to be implemented before 13 August 2007.

4. Proposal – NZFSA proposes option 2 (paragraph 7.2)

5. Impact on industry

6. Impact on consumers

7. Any other comments